Navigation Links
Colorcon and BASF Announce Collaboration to Develop Film Coating Applications Using Kollicoat® Smartseal 30 D

HARLEYSVILLE, Pa. and LUDWIGSHAFEN, Germany, Oct. 20, 2011 /PRNewswire/ -- Colorcon, Inc. and BASF have announced a collaboration for the development of future film coating systems using Kollicoat® Smartseal 30 D, and a new Colorcon pre-formulated additive.

Colorcon has developed a pre-formulated additive system for use with Kollicoat Smartseal 30 D which enables efficient preparation and application of this polymer in taste masking applications. The pre-formulated additive lowers the number of materials to be dispensed by 50% and reduces the preparation time by almost 40%.

"We have chosen Kollicoat Smartseal 30 D because it is the best-in-class reverse enteric polymer for taste masking," said Kamlesh Oza, General Manager Film Coating at Colorcon. "Kollicoat Smartseal 30 D is the first water-based dispersion having both taste masking and moisture barrier properties. It was developed to simplify and accelerate aqueous film coating operations, and opens new doors for formulating tablet, pellet, and particle coatings. Our collaboration to develop the additive will bring batch-to-batch color consistency, performance, speed and simplicity enabling easy reconstituting of the film former in pharmaceutical coating operations while maintaining functionality."

"Smartseal 30 D is the latest innovation in our Kollicoat portfolio, which completes the formulator toolbox by adding taste masking and moisture protection to the functionalities. We are very happy that the market leader in film-coating will closely collaborate with us in this application area," said Dr. Ralf Fink, Vice President Global Marketing Pharma Ingredients at BASF.

During the Annual Meeting of the American Association of Pharmaceutical Scientists meeting in Washington, D.C. next week, both companies will present some of the latest research on Kollicoat Smartseal 30 D.  Colorcon will present a poster entitled "Performance Characteristics and Formulation of Kollicoat Smartseal 30 D."  BASF will have a poster with the title "Taste-masking of crystals by coating with an innovative methacrylate copolymer."

About Colorcon

Colorcon is a world leader in the development, supply and support of formulated products for the pharmaceutical and nutritional industries. Its core businesses include film coatings, modified release technologies, functional excipients and tablet design services. Colorcon has 18 technical service laboratories globally and more than 1200 employees exclusively dedicated to its customer base.  For more information, visit  

About BASF

BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics, performance products and agricultural products to oil and gas. As a reliable partner BASF creates chemistry to help its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges such as climate protection, energy efficiency, nutrition and mobility. BASF posted sales of about euro 63.9 billion in 2010 and had approximately 109,000 employees as of the end of the year. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is available on the Internet at or in its Social Media Newsroom at

SOURCE Colorcon
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Colorcon, Inc. Introduces Opadry® 200 Optimized Performance Film Coatings
2. Colorcon Reaffirms World-Wide Patent Positions for Enteric Coating Compositions
3. Colorcon Expands Nutraficient Product Portfolio to Include High Productivity, PVA-Based Formulations for Food Supplement Coating
4. Colorcon Acquires Business of Pharmaceutical Coatings Pvt. Ltd. (India)
5. Colorcon Acquires Pharmaceutical Excipient Company - NP Pharm
6. ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
7. ChromaDex Announces Appointment of Barry Honig, Michael Brauser and William Spengler to Its Board of Directors
8. Onyx Pharmaceuticals Announces Third Quarter 2011 Financial Results Teleconference and Webcast
9. Jazz Pharmaceuticals Announces Third Quarter 2011 Results Conference Call on November 1
10. Rochester Medical Announces Fourth Quarter 2011 Earnings Conference Call Thursday, November 3, 2011
11. InaVein, LLC Announces First Peer-reviewed Publication of TRIVEX® Used In-Office
Post Your Comments:
(Date:12/1/2015)... Sverige, December 1, 2015 ... Cancer Study Group (IBCSG, Bern ... ingå i en klinisk studie av palbociclib, ett ... --> Studien, med namn PYTHIA, kommer ... anti-hormonella läkemedel i kombination med palbociclib, som tillhör ...
(Date:11/30/2015)... , Dec. 1, 2015 Researchers have developed ... body part thickness and checks for motion, positioning and ... feasibility study presented today at the annual meeting of ... (RSNA). Steven Don , M.D., associate ... University School of Medicine in St. Louis, ...
(Date:11/30/2015)... Die MEDTEC Japan 2016, ... Entwicklung und Herstellung medizinischer Geräte, findet ... in Tokyo ... Foto: ... --> ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... December 01, 2015 , ... ... as a 2015-2016 inductee into its VIP Woman of the Year Circle. ... the nation’s leading networking organization exclusively for professional women, boasting 850,000 members and ...
(Date:11/30/2015)... (PRWEB) , ... December 01, 2015 , ... ... Dale Jones as a 2015-2016 inductee into its VIP Woman of ... education. NAPW is the nation’s leading networking organization exclusively for professional women, boasting ...
(Date:11/30/2015)... , ... December 01, 2015 , ... ... latest carrier to offer individual vision insurance plans on . The ... ability to rate and review products, allowing consumers to compare, quote and match ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... Until now, ... criteria set forth in the MOMS (Management of Myelomeningocele Study) trial. One of these ... Control and Prevention), a BMI of 18.5 to 24.9 is considered normal, 25 - ...
(Date:11/30/2015)... ... November 30, 2015 , ... Stress, anxiety, illness, infection or ... worry about possible tumors? , Heather Spader, MD, a new pediatric neurosurgeon at Joe ... some signs might point to tumors. , “Bad headaches that don’t go ...
Breaking Medicine News(10 mins):